FOSUN INTL LTD/ HK0656038673 /
2024-08-29 11:00:09 PM | Chg. +0.012 | Volume | Bid11:00:09 PM | Ask11:00:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.479EUR | +2.57% | - Turnover: - |
0.479Bid Size: - | 0.498Ask Size: - | 4.48 bill.EUR | - | - |
GlobeNewswire
08-16
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire
08-08
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
08-01
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
07-31
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Tri...
GlobeNewswire
07-30
BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire
07-22
BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire
07-19
LAKE (LAK3) Announces Strategic Partnership with Premier League Club Wolverhampton Wanderers FC
GlobeNewswire
07-17
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinical...
GlobeNewswire
06-28
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...
GlobeNewswire
06-27
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire
06-24
BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire
06-01
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire
05-29
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire
05-21
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire
05-21
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...